Showing results (81-90 of 211) with videos related to

Sort By:
Pageof 22
Pharmacogenetics and Genomics|February 7, 2026
The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposureKatherine Zhao, Vy Lam, Gregory Eschenauer, et al.
JCO Precision Oncology|April 30, 2026
Lipidomic Predictors of Paclitaxel-Induced Peripheral NeuropathyYaping Liu, Ciao-Sin Chen, Nam Nguyen-Hoang, et al.
Pharmacogenomics|August 24, 2023
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanismsErin Harleton, Marie Webster, Namandjé N Bumpus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2026
Identification of additional DPYD polymorphisms that increase the risk of severe fluoropyrimidine toxicity and improved predictive accuracy when combined with previously validated variantsNam Nguyen-Hoang, Kelly Nugent, Sophia Jaso, et al.
Cancer Research|April 6, 2006
Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumorsChad J Creighton, Amy M Hilger, Shalini Murthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2008
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6Natasha T Snider, Matthew J Sikora, Chitra Sridar, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2005
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing schemeAnne F Schott, James M Rae, Kent A Griffith, et al.
Pharmacogenomics and Personalized Medicine|March 22, 2021
Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving TacrolimusAmy L Pasternak, Vincent D Marshall, Christina L Gersch, et al.
Breast Cancer Research and Treatment|April 25, 2012
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxelDaniel L Hertz, Alison A Motsinger-Reif, Amy Drobish, et al.
Pageof 22